Brief: Scilex Announces S-4 Effectiveness for Denali–Semnur Merger Proposal
13/08/2025 12:33
Aug 13 (Reuters) - Denali Capital Acquisition Corp DNQAF.PK: SCILEX HOLDING COMPANY (NASDAQ: SCLX) ANNOUNCES EFFECTIVENESS OF REGISTRATION STATEMENT ON FORM S-4 FOR THE PROPOSED BUSINESS COMBINATION OF DENALI CAPITAL ACQUISITION CORP. AND SEMNUR PHARMACEUTICALS, INC., A MAJORITY-OWNED SUBSIDIARY OF SCILEX Source text: ID:nGNX19XflW Further company coverage: DNQAF.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Semnur Pharmaceuticals
See all newsBrief: Scilex Holding Announces Signing Of Securities Purchase Agreement With An Institutional Investor
Brief: Scilex Announces S-4 Effectiveness for Denali–Semnur Merger Proposal
Brief: Denali Capital Shareholders Approve Extension For Business Combination Deadline
Brief: Denali Capital Acquisition Announces Extension Of Deadline To Complete Business Combination
Brief: Denali Capital Acquisition Corp. Announces Extension Of Deadline To Complete Business Combination